Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a new human pathogen in late 2019 and it has infected over 100 million people in less than a year. There is a clear need for effective antiviral drugs to complement current preventive measures, including vaccines. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Varghese, Finny S., van Woudenbergh, Esther, Overheul, Gijs J., Eleveld, Marc J., Kurver, Lisa, van Heerbeek, Niels, van Laarhoven, Arjan, Miesen, Pascal, den Hartog, Gerco, de Jonge, Marien I., van Rij, Ronald P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918080/
https://www.ncbi.nlm.nih.gov/pubmed/33670363
http://dx.doi.org/10.3390/v13020282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918080/
https://www.ncbi.nlm.nih.gov/pubmed/33670363
http://dx.doi.org/10.3390/v13020282

Ejemplares similares